Gastroparesis is a condition where the stomach empties food much more slowly than it should, even though there isn’t a blockage. As food sits in the stomach longer, people may experience nausea, vomiting, bloating, feeling full after just a few bites, abdominal pain, and sometimes weight loss.
What Is Gastroparesis? August is Gastroparesis Awareness Month, an opportunity to raise awareness about a digestive disorder that affects an estimated 5 million people in the United States. Although gastroparesis has long been recognized by gastroenterologists, it has recently gained public attention because of the widespread use of GLP-1 receptor agonists for...
The U.S. Food and Drug Administration recently announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. The participating manufacturer intends to offer a device for use in providing care expected to be covered by the Centers for Medicare & Medicaid Services (CMS) Innovation...
Diabetes can affect many parts of the body, but one of the most serious complications involves the kidneys. Over time, high blood sugar can damage the tiny blood vessels that help the kidneys filter waste and extra fluid from the blood. This condition is called diabetic kidney disease, also known as diabetic nephropathy. It is the leading cause of chronic kidney disease and kidney failure worldwide.
Retatrutide is making big news after strong research results from its Phase 3 clinical trial. The drug, which is being developed by Eli Lilly, is designed to treat obesity and overweight. What makes it different is that it targets three hormone pathways instead of just one.
In the large Phase 3 TRIUMPH-1 trial, retatrutide helped people lose large amounts of weight over 80 weeks. Some results were close to what doctors usually see with weight loss surgery.
Here is what we know so far.
Type 2 diabetes happens when the body cannot properly control blood sugar. Over time, high blood sugar can damage the heart, kidneys, nerves, and eyes. Many treatments are available, including a group of medications called GLP-1 receptor agonists. These drugs help the body release insulin, lower blood sugar, and often support weight loss.
But not everyone responds to GLP-1 medications the same way. A new study published in Genome Medicine explored why. Researchers found that certain genetic differences may influence natural GLP-1 hormone levels and how well GLP-1 medications work.